Egot, Baby Girl .
HRN: 22-25-78 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/29/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
11/29/2022
12/06/2022
IV
25 Mg
Q24
PSNB; PREMATURITY
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes